Essential role of apelin signaling during lymphatic development in Zebrafish

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 2, 2014, Pages 338-345

  Kim, Jun Dae ^a   Kang, Yujung ^a   Kim, Jongmin ^b   Papangeli, Irinna ^a   Kang, Hyeseon ^a   Wu, Jingxia ^a   Park, Hyekyung ^a   Nadelmann, Emily ^a   Rockson, Stanley G ^c   Chun, Hyung J ^a   Jin, Suk Won ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sookmyung Women's University   (South Korea)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apelin protein; APJ receptor; lymphatic vessels; zebrafish

Indexed keywords

APELIN PROTEIN; APJ RECEPTOR; LYMPHATIC VESSELS; ZEBRAFISH;

ANIMALS; CELLS, CULTURED; CHEMOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, LYMPHATIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHANGIOGENESIS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE; SIGNAL TRANSDUCTION; THORACIC DUCT; TIME FACTORS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84893355100     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.302785     Document Type: Article

References (43)

1. Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell. 2010;140:460-476
2. Alitalo K. The lymphatic vasculature in disease. Nat Med. 2011;17:1371-1380
3. Schulte-Merker S, Sabine A, Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol. 2011;193:607-618
4. Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell. 2005;7:121-127
5. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9:239-252
6. Murdaca G, Cagnati P, Gulli R, Spanò F, Puppo F, Campisi C, Boccardo F. Current views on diagnostic approach and treatment of lymphedema. Am J Med. 2012;125:134-140
7. Witte MH, Dellinger MT, Papendieck CM, Boccardo F. Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia. Clin Exp Metastasis. 2012;29:707-727
8. Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann N Y Acad Sci. 2008;1131:147-154
9. Brorson H, Ohlin K, Olsson G, Svensson B, Svensson H. Controlled compression and liposuction treatment for lower extremity lymphedema. Lymphology. 2008;41:52-63
10. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 1999;98:769-778
11. van der Putte SC. The development of the lymphatic system in man. Adv Anat Embryol Cell Biol. 1975;51:3-60
12. Yaniv K, Isogai S, Castranova D, Dye L, Hitomi J, Weinstein BM. Live imaging of lymphatic development in the zebrafish. Nat Med. 2006;12:711-716
13. Küchler AM, Gjini E, Peterson-Maduro J, Cancilla B, Wolburg H, Schulte-Merker S. Development of the zebrafish lymphatic system requires VEGFC signaling. Curr Biol. 2006;16:1244-1248
14. Francois M, Harvey NL, Hogan BM. The transcriptional control of lymphatic vascular development. Physiology (Bethesda). 2011;26:146-155
15. Ny A, Koch M, Schneider M, et al. A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat Med. 2005;11:998-1004
16. Kidoya H, Takakura N. Biology of the apelin-APJ axis in vascular formation. J Biochem. 2012;152:125-131
17. Zeng XX, Wilm TP, Sepich DS, Solnica-Krezel L. Apelin and its receptor control heart field formation during zebrafish gastrulation. Dev Cell. 2007;12:391-402
18. Scimia MC, Hurtado C, Ray S, et al. APJ acts as a dual receptor in cardiac hypertrophy. Nature. 2012;488:394-398
19. Scott IC, Masri B, D'Amico LA, Jin SW, Jungblut B, Wehman AM, Baier H, Audigier Y, Stainier DY. The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors. Dev Cell. 2007;12:403-413
20. Sheikh AY, Chun HJ, Glassford AJ, et al. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol. 2008;294:H88-H98
21. Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY, Finsterbach TP, Leeper NJ, Ernst KV, Chen MM, Ho YD, Chun HJ, Bernstein D, Ashley EA, Quertermous T. Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol. 2009;297:H1904-H1913
22. Kang Y, Kim J, Anderson JP, Wu J, Gleim SR, Kundu R, McLean DL, Kim JD, Park H, Jin SW, Hwa J, Quertermous T, Chun HJ. Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development. Circ Res. 2013;113:22-31
23. Tucker B, Hepperle C, Kortschak D, Rainbird B, Wells S, Oates AC, Lardelli M. Zebrafish Angiotensin II Receptor-like 1a (agtrl1a) is expressed in migrating hypoblast, vasculature, and in multiple embryonic epithelia. Gene Expr Patterns. 2007;7:258-265
24. McLean DL, Kim J, Kang Y, Shi H, Atkins GB, Jain MK, Chun HJ. Apelin/ APJ signaling is a critical regulator of statin effects in vascular endothelial cells-brief report. Arterioscler Thromb Vasc Biol. 2012;32:2640-2643
25. Sawane M, Kidoya H, Muramatsu F, Takakura N, Kajiya K. Apelin attenuates UVB-induced edema and inflammation by promoting vessel function. Am J Pathol. 2011;179:2691-2697
26. Sawane M, Kajiya K, Kidoya H, Takagi M, Muramatsu F, Takakura N. Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity. Diabetes. 2013;62:1970-1980
27. Li Y, Chen J, Bai B, Du H, Liu Y, Liu H. Heterodimerization of human apelin and kappa opioid receptors: Roles in signal transduction. Cell Signal. 2012;24:991-1001
28. Hashimoto Y, Ishida J, Yamamoto R, Fujiwara K, Asada S, Kasuya Y, Mochizuki N, Fukamizu A. G protein-coupled APJ receptor signaling induces focal adhesion formation and cell motility. Int J Mol Med. 2005;16:787-792
29. Hong CC, Peterson QP, Hong JY, Peterson RT. Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ ERK signaling. Curr Biol. 2006;16:1366-1372
30. Hong CC, Kume T, Peterson RT. Role of crosstalk between phosphatidylinositol3-kinase and extracellular signal-regulated kinase/ mitogenactivated protein kinase pathways in artery-vein specification. Circ Res. 2008;103:573-579
31. Ren B, Deng Y, Mukhopadhyay A, Lanahan AA, Zhuang ZW, Moodie KL, Mulligan-Kehoe MJ, Byzova TV, Peterson RT, Simons M. ERK1/2-Akt1crosstalk regulates arteriogenesis in mice and zebrafish. J Clin Invest. 2010;120:1217-1228
32. Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, Timms JF, Waterfield MD. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J. 2007;404:15-21
33. Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, Reichling LJ, Sim T, Sabatini DM, Gray NS. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.J Biol Chem. 2009;284:8023-8032
34. Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Lüthi U, Barberis A, Benjamin LE, Mäkinen T, Nobes CD, Adams RH. Ephrin-B2 controls VEGFinduced angiogenesis and lymphangiogenesis. Nature. 2010;465:483-486
35. Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res. 2001;49:568-581
36. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling- in control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359-371
37. Zhou F, Chang Z, Zhang L, Hong YK, Shen B, Wang B, Zhang F, Lu G, Tvorogov D, Alitalo K, Hemmings BA, Yang Z, He Y. Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. Am J Pathol. 2010;177:2124-2133
38. Morello F, Perino A, Hirsch E. Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res. 2009;82:261-271
39. Coso S, Zeng Y, Opeskin K, Williams ED. Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis. PLoS One. 2012;7:e39558
40. Aguilar B, Choi I, Choi D, et al. Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor. Cancer Res. 2012;72:5833-5842
41. Morris VA, Punjabi AS, Lagunoff M. Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-Associated herpesvirus-induced lymphatic reprogramming of endothelial cells. J Virol. 2008;82:8771-8779
42. Hers I, Vincent EE, Tavaré JM. Akt signalling in health and disease. Cell Signal. 2011;23:1515-1527
43. Hemmings BA, Restuccia DF. PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol. 2012;4:a011189